A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.
作者信息
Alqahtani Saleh, Federico Paolo, Myers Robert P
机构信息
Liver Unit, Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, Alta.
出版信息
CMAJ. 2007 Sep 11;177(6):568-9. doi: 10.1503/cmaj.061272.
Abstract
摘要
相似文献
1
A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.
CMAJ. 2007 Sep 11;177(6):568-9. doi: 10.1503/cmaj.061272.
2
Possible new clinical sign of hyperammonemia.
CMAJ. 2008 Jan 29;178(3):326; author reply 326. doi: 10.1503/cmaj.1070139.
3
Valproate-induced hyperammonemic encephalopathy with normal liver function.
Neurol India. 2005 Jun;53(2):226-8. doi: 10.4103/0028-3886.16420.
4
Valproate-induced hyperammonemic encephalopathy: imaging findings on diffusion-weighted MRI.
Eur Neurol. 2004;52(3):178-81. doi: 10.1159/000081861. Epub 2004 Nov 2.
5
[Hyperammonemic encephalopathy associated with valproate acid].
Neurologia. 2003 Jul-Aug;18(6):347-50.
6
Acute hyperammonemic coma with chronic valproic acid therapy.
Ann Pharmacother. 2005 Dec;39(12):2119-23. doi: 10.1345/aph.1G167. Epub 2005 Nov 15.
7
Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
Ren Fail. 2008;30(8):822-4. doi: 10.1080/08860220802272613.
8
Valproate-induced hyperammonemic encephalopathy without cognitive sequelae: a case report in the psychiatric setting.
J Neuropsychiatry Clin Neurosci. 2008 Summer;20(3):369-71. doi: 10.1176/jnp.2008.20.3.369.
9
Valproate-induced hyperammonemic encephalopathy and normal liver functions: possible synergism with topiramate.
Clin Neuropharmacol. 2009 Nov-Dec;32(6):350-2. doi: 10.1097/WNF.0b013e3181ac3615.
10
Valproate-induced encephalopathy.
J Coll Physicians Surg Pak. 2005 Sep;15(9):571-2.
引用本文的文献
1
Carbamazepine induced asterixis with hyperammonemia: a case report with review of literature.
Indian J Psychol Med. 2015 Jan-Mar;37(1):99-101. doi: 10.4103/0253-7176.150853.
2
Valproate-induced encephalopathy with predominant pancerebellar syndrome.
Indian J Pharmacol. 2012 Jan;44(1):129-30. doi: 10.4103/0253-7613.91886.
3
Possible new clinical sign of hyperammonemia.
CMAJ. 2008 Jan 29;178(3):326; author reply 326. doi: 10.1503/cmaj.1070139.
本文引用的文献
1
Valproate-induced hyperammonemic encephalopathy.
Acta Neurol Scand. 2006 Jul;114(1):1-7. doi: 10.1111/j.1600-0404.2006.00655.x.
2
Valproate-induced hyperammonemic encephalopathy.
Metab Brain Dis. 2002 Dec;17(4):367-73. doi: 10.1023/a:1021918104127.
3
Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy.
Postgrad Med J. 2001 Nov;77(913):717-22. doi: 10.1136/pmj.77.913.717.
4
Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.
Neurology. 1982 Feb;32(2):206-8. doi: 10.1212/wnl.32.2.206.
5
Secondary hyperammonaemia: a possible mechanism for valproate encephalopathy.
Lancet. 1980 Jun 14;1(8181):1310-1. doi: 10.1016/s0140-6736(80)91773-0.
6
Hyperammonaemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other antiepileptic drugs.
Br J Clin Pharmacol. 1986 Jul;22(1):100-3.
Zotero 插件